BioSpace News Archive

Drug Development

Genmab and Johnson & Johnson’s Darzalex Dazzles in Multiple Myeloma Trial

Denmark-based Genmab A/S released topline data from its Phase III MAIA trial of a drug it licensed to Johnson & Johnson’s Janssen Biotech, Darzalex (daratumumab).

October 30, 2018
·
2 min read
·
Mark Terry
Drug Development

Study: Excessive Daytime Sleepiness Linked to Alzheimer’s Disease

There is increasing evidence that there is some sort of association between sleep problems and dementias such as Alzheimer’s disease. This was further linked with a recent research study published in the journal Sleep.

October 30, 2018
·
3 min read
·
Mark Terry
Biotech Beach

LA BioMed Launches Groundbreaking Study on Deadly Skin Infections

$5.3 million NIH grant will fund research on effective therapies for antibiotic-resistant strains

October 30, 2018
·
2 min read
Policy

Promore Pharma has had a successful meeting with the FDA regarding PXL01

Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that that it has had a successful meeting with the US Food and Drug Administration (FDA) regarding the continued development of PXL01.

October 30, 2018
·
4 min read
Business

Eisai: Application Seeking Manufacturing and Marketing Approval in Japan Submitted for Parkinson’s Disease Treatment Safinamide

Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. announced that an application seeking manufacturing and marketing approval in Japan was submitted as of today by Meiji for the Parkinson’s disease treatment ME2125 (safinamide mesylate, “safinamide”).

October 30, 2018
·
5 min read
Racial differences in colorectal cancer incidence not due to biology

Higher rates in blacks appear to be linked to access to screening

October 30, 2018
·
3 min read
Business

Adocia Announces Third Quarter 2018 Financial Results

Cash position of EUR 44.2 million as of September 30, 2018

October 30, 2018
·
6 min read
Business

Glenmark Pharmaceuticals Celebrates Inauguration of $100 Million Facility in Monroe, N.C.

Glenmark Pharmaceutical will hold an inauguration ceremony of its manufacturing facility built in Monroe, N.C. on Tuesday, October 30, at 10:30 a.m.

October 30, 2018
·
1 min read
Business

CMDO Debra Barker to leave Polyphor; Frank Weber to assist in the transition

Chief Medical and Development Officer Debra Barker has decided to leave Polyphor at year end for personal reasons and will support on a part time basis afterwards.

October 30, 2018
·
2 min read
Balixafortide combination with eribulin in metastatic breast cancer data presented at ESMO 2018 show consistent positive trend for all efficacy endpoints, including overall survival

Polyphor presented new efficacy data on its immuno-oncology candidate, balixafortide, at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany.

October 30, 2018
·
4 min read